Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00788801 | Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain | PHASE1 | COMPLETED | 11 | — | — | Dec 1, 2008 | - | Nov 2, 2010 | 2 | Canada |
| Arm | Type | Description |
|---|---|---|
| Baseline | EXPERIMENTAL | - |
| ABT-614 Low Dose | EXPERIMENTAL | - |
| ABT-614 High Dose | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| ABT-614 | DRUG | Baseline PET scan with radiotracer only, PET scan with radiotracer and ABT-614 Low Dose or ABT-614 High Dose |
Inclusion Criteria: 1. Body Mass Index (BMI) is 18 to 26 kg/m2, inclusive 2. A condition of general good physical health based upon the results of a medical history, physical examination, vital signs, laboratory profile, 12-lead electrocardiogram (ECG) Exclusion Criteria: 1. Presence of a metal i...